A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

Dold C, Oguti B, Silva-Reyes L, Stanzelova A, Raymond M, Smith CC, Moore M, Barton A, Choi EM, Plested E, Tanha K, Louth J, Holland A, Cook R, King J, Lucidarme J, Borrow R, Hill AVS, Beernink PT, Liu X, Pollard AJ, Rollier CS